Report Overview

The global gastrointestinal OTC drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The major factors that contribute to the growth of the gastrointestinal OTC drugs market include the increasing prevalence of gastrointestinal diseases, high adoption of OTC drugs as they are cost-effective & convenient to buy, advancements in R&D activities such as innovations in drugs, and high demand for self-diagnosis and self-medication. However, factors such as stringent government regulations and inadequate reimbursements provided for gastrointestinal OTC drugs hinder the market growth. Conversely, growth in public awareness and increase in healthcare expenditures are expected to provide numerous opportunities for the market growth soon.



Market Drivers

Rising prevalence of gastrointestinal diseases or disorders and rising R&D activities globally for easily availability of OTC drugs are driving market growth.

However, technological advancement for self-diagnosis for gastrointestinal diseases and easy availability and cost effective of the OTC drugs also boost up the market growth. Moreover, rising demand for OTC drugs and rising population with gastrointestinal diseases in the developed as well as developing countries act as opportunity for the market growth. But sometimes adverse effect related to the drugs, inadequate knowledge of the medication and stringent regulatory guidelines for the approval and commercialization of OTC drugs may hamper the global gastrointestinal OTC drugs market.

Gastrointestinal OTC is purchased without the doctor prescription that is anyone can purchase the medicine. Globally, half of the population suffering from some gastrointestinal diseases and so many peoples use over the counter (OTC) drugs to treat minor gastrointestinal problems. Moreover, OTC drugs are the first line treatment of any type of gastrointestinal diseases or disorders such as heartburn, gastroesophageal reflux disease (GERD) among others.